Type 2 Diabetes Trial, Recruiting (NCT07091162)

Type 2 Diabetes Trial, Recruiting NCT07091162 Sponsor: Monash University Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07091162 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 40 years old or older
You have been diagnosed with type 2 diabetes
Your medical scans are clear enough to be used by the study's imaging system (confirm with trial site)
Your genetic risk score can be calculated using your available information (confirm with trial site)

Who may not be able to join:

You are unable or unwilling to sign a written consent form agreeing to take part
You are not willing to come back for repeat check-ups and assessments over the course of the study
You already have a known heart or blood vessel disease
Your CT heart scan shows significant blockages in your heart arteries — specifically a blockage of 50% or more in the main left heart artery, or 70% or more in any of the major heart arteries
The study doctor does not think you are able to fully take part in or complete all the required parts of the study for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen J Nicholls, MBBS, PhD, Monash University

Phone: 0423245187

Australian sites

Victorian Heart Hospital, Melbourne, Victoria
+61 3 7511 1243

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07091162

Sponsor: Monash University

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 0423245187

More information: https://clinicaltrials.gov/study/NCT07091162

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 40 years old or older
You have been diagnosed with type 2 diabetes
Your medical scans are clear enough to be used by the study's imaging system (confirm with trial site)
Your genetic risk score can be calculated using your available information (confirm with trial site)

Who may not be able to join:

You are unable or unwilling to sign a written consent form agreeing to take part
You are not willing to come back for repeat check-ups and assessments over the course of the study
You already have a known heart or blood vessel disease
Your CT heart scan shows significant blockages in your heart arteries — specifically a blockage of 50% or more in the main left heart artery, or 70% or more in any of the major heart arteries
The study doctor does not think you are able to fully take part in or complete all the required parts of the study for any reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Monash University

Registry

ClinicalTrials.gov

Start date

25 July 2023

Est. completion

1 July 2026

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in non-calcified plaque volume, with Bonferroni correction at 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov